Ethical issues in newborn screening research: Lessons from the Wisconsin cystic fibrosis trial

Journal of Pediatrics

Volumn 145, Issue 3, 2004, Pages 292-296

  Taylor, Holly A ^a   Wilfond, Benjamin S ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

CF; Cystic fibrosis; Immunoreactive trypsinogen; Institutional review board; IRB; IRT; NBS; Newborn screening

Indexed keywords

TRYPSINOGEN;

ACCURACY; BLOOD SAMPLING; CLINICAL TRIAL; CYSTIC FIBROSIS; DOCUMENTATION; HEALTH PROGRAM; HUMAN; IMMUNOREACTIVITY; INTERPERSONAL COMMUNICATION; LEGAL ASPECT; MEDICAL ETHICS; MEDICAL RESEARCH; METHODOLOGY; NEWBORN SCREENING; NOTE; PARENTAL CONSENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; RESPONSIBILITY; SCREENING TEST;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH; GENETICS AND REPRODUCTION;

CYSTIC FIBROSIS; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; PARENTAL CONSENT; WISCONSIN;

EID: 4444299674     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2004.04.010     Document Type: Note

References (38)

1. McCabe L.L., Therrell B.L. Jr., McCabe E.R. Newborn screening: rationale for a comprehensive, fully integrated public health system. Mol Genet Metab. 77:2002;267-273
2. Khoury M.J., McCabe L.L., McCabe E.R. Population screening in the age of genomic medicine. N Engl J Med. 348:2003;50-58
3. Wilfond B., Thomson E.J. Models of Public Health Genetic Policy Development. Khoury M., Burke W., Thomson E. Genetics and Public Health in the 21st Century: Using Genetic Information to Improve Health and Prevent Disease. 2000;61-81 Oxford University Press, New York, NY
4. Burke W. Genetic testing. N Engl J Med. 347:2002;1867-1875
5. Burke W., Atkins D., Gwinn M., et al. Genetic test evaluation: information needs of clinicians, policy makers, and the public. Am J Epidemiol. 156:2002;311-318
6. Andrews L.B., Fullerton J.E., Hotzman N.A., Motolsky A.G. Assessing Genetic Risks: Implications for Health and Social Policy. 1994;National Academy Press, Washington DC
7. Committee on Inborn Errors of Metabolism. Genetic Screening: Programs, Principles, and Research. 1975;National Academy of Sciences, Washington, DC
8. Holtzman N.A., Watson M.S. Promoting Safe and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic Testing. 1997;National Human Genome Research Institute, Bethesda, Md
9. Newborn screening for sickle cell disease and other hemoglobinopathies. Natl Inst Health Consens Dev Conf Consens Statement. 6:1987;1-8
10. Centers for Disease Control and Prevention. Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development: proceedings of a 1997 workshop. MMWR. 46:1997;1-24
11. Bradley D.M., Parsons E.P., Clarke A.J. Experience with screening newborns for Duchenne muscular dystrophy in Wales. BMJ. 306:1993;357-360
12. Bailey D.B. Jr., Skinner D., Sparkman K.L. Discovering fragile X syndrome: family experiences and perceptions. Pediatrics. 111:2003;407-416
13. Buckley R.H., Schiff R.I., Schiff S.E., et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr. 130:1997;378-387
14. Atkinson K., Zuckerman B., Sharfstein J.M., Levin D., Blatt R.J., Koh H.K. A public health response to emerging technology: expansion of the Massachusetts newborn screening program. Public Health Rep. 116:2001;122-131
15. Nelson R.M., Botkin J.R., Kodish E.D., et al. Ethical issues with genetic testing in pediatrics. Pediatrics. 107:2001;1451-1455
16. Fost N., Farrell P.M. A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma. Clin Res. 37:1989;495-500
17. Ande V. Rock. 647 N.W. 2d 265. 2002.
18. Begley S. Case involving tests on newborns shows need for strict ethics. Wall Street Journal. May 3, 2002;B1
19. Farrell P.M. Improving the health of patients with cystic fibrosis through newborn screening: Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Adv Pediatr. 47:2000;79-115
20. Neonatal screening for cystic fibrosis: position paper. Pediatrics. 72:1983;741-745
21. Gregg R.G., Wilfond B.S., Farrell P.M., Laxova A., Hassemer D., Mischler E.H. Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols. AJHG. 52:1993;616-626
22. Wilfond B., Taussig L.M. Cystic Fibrosis: Clinical Overview. Taussig L.M., Landau L.I. Textbook of Pediatric Pulmonary Medicine. 1999;982-990 Mosby-YearBook, St Louis, Mo
23. Cystic Fibrosis Patient Registry, 2001 Annual Data Report. Bethesda, Md: 2002.
24. Wilfond B., Rothenberg L.S. Ethical issues in cystic fibrosis newborn screening: from data to public health policy. Curr Opin Pulm Med. 8:2002;529-534
25. 45 C.F.R. §46.117(c). Protection of Human Subjects, 2001.
26. 45 C.F.R. §46.102(i). Protection of Human Subjects, 2001.
27. Clayton E.W. Screening and treatment of newborns. Houston Law Review. 29:1992;85-148
28. Serving the family from birth to the medical home: a report from the Newborn Screening Task Force convened in Washington, DC, May 10-11, 1999. Pediatrics. 106:2000;383-427
29. Wendler D., Rackoff J.E. Informed consent and respecting autonomy: what's a signature got to do with it? IRB. 23:2001;1-4
30. New England Newborn Screening Program. What parents should know: Accessed September 15, 2003 at http://www.umassmed.edu/nbs/brochures; 2003.
31. Tluczek A., Mischler E.H., Farrell P.M., et al. Parents' knowledge of neonatal screening and response to false-positive cystic fibrosis testing. J Dev Behav Pediatr. 13:1992;181-186
32. Paasche-Orlow M.K., Taylor H.A., Brancati F.L. Readability standards for informed-consent forms as compared with actual readability. N Engl J Med. 348:2003;721-726
33. Davis T.C., Holcombe R.F., Berkel H.J., Pramanik S., Divers S.G. Informed consent for clinical trials: a comparative study of standard versus simplified forms. J Natl Cancer Inst. 90:1998;668-674
34. Davis T.C., Michielutte R., Askov E.N., Williams M.V., Weiss B.D. Practical assessment of adult literacy in health care. Health Educ Behav. 25:1998;613-624
35. Baker H., Uus K., Bamford J., Marteau T. Increasing knowledge about a screening test: preliminary evidence of a structured, chart based, screener presentation. Patient Education and Counseling. 52:2004;107-112
36. Ross L.F. Predictive genetic testing for conditions that present in childhood. Kennedy Inst Ethics J. 12:2002;225-244
37. Kodish E., Eder M., Noll R.B., et al. Communication of Randomization in Childhood Leukemia Trials. JAMA. 291:2004;470-475
38. Farrell P.M., Kosorok M.R., Laxova A., et al. Nutritional benefits of neonatal screening for cystic fibrosis. N Engl J Med. 337:1997;963-969